Recruited patients & number of trials

solid tumors N Studies
   
Breast Cancer 126
Colorectal Cancer 51
HNO 17
Gastric Cancer 18
NSCLC 27
Pancreas Carcinoma 15
HCC 2
RCC 11
Braintumor 6
Prostate Cancer 8
Melanoma 9
Esophageal Carcinoma 3
Sarcoma 2
Thyroid cancer 3
Neuroendocrine Tumor 3
Ovarian Cancer 4
GIST 4
Other indications 28
Total 337
   


hematological malignancies N Studies
   
NHL 78
MDS 13
MMyelom 39
AML 25
CML 15
HD 14
Myelofibrosis 4
ALL 8
ITP 3
PV 3
CMML 1
ET 1
Mastocytosis 1
Other Indications 22
Total 227
   


Rheumatology N Studies
   
Total 14
   


Infectiology N Studies
   
Total 18
   
Grand Total 596
  • Our Current clinical trials

     

    Breast cancer

    Colorectal cancer

    Gastrointestinal tumor

    Hepatocellular carcinoma

    Renal cell carcinoma

    Lung carcinoma

    HNO tumor

    Esophageal tumor

    Brain tumours/ Glioblastoma

    Pancreas carcinoma

    Neuroendocrine tumor

    Prostate cancer

    Thyroid carcinoma

    Ovarian cancer

    Melanoma

    Soft Tissue Sarcomas

    Lymphomas:

    Diffuse large B Cell Lymphoma
    Follicular lymphoma
    Marginal-zone lymphoma
    Peripheral T-cell lymphoma
    Chronic lymphocytic leukaemia (CLL)
    Mantle cell lymphoma
    Hodgkin disease

    Leukaemia:

    Acute myeloid leukaemia (AML)
    Acute lymphoblastic leukemia (ALL)

    Immune Thrombocytopenia (ITP)

    Myelodysplastic syndrome

    Chronic myelo-monocytic leukemia (CMML)

    Plasmacytoma / Multiple myeloma

    Myeloproliferative diseases:

    Essential thrombocythaemia (ET)
    Polycythemia vera (PV)
    Chronic myelogenous leukemia (CML)

    Mastocytosis

    Rheumatoid arthritis

    HIV